Skip to search formSkip to main contentSkip to account menu

epirubicinol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
The optimization of a liquid chromatographic separation of four anthracyclines (doxorubicin, epirubicin, daunorubicin and… 
2004
2004
In a pharmacokinetics study, six patients were treated i.v. with epirubicin (EPI) at the two dose levels of 60 and 120 mg/m2… 
2004
2004
SummaryThirteen cancer patients were studied following a total of 41 courses of epirubicin (EPI) (38–50 mg·m−2, mean 49.2 mg·m−2… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND The objectives of this study were to investigate the disposition of gemcitabine, epirubicin, paclitaxel, 2',2… 
2002
2002
BACKGROUND The objective of this phase I trial was to determine the maximally tolerated doses of the combination of docetaxel… 
Highly Cited
1999
Highly Cited
1999
PURPOSE To investigate whether paclitaxel and docetaxel influence the pharmacokinetics and metabolism of epirubicin. PATIENTS… 
1998
1998
This phase I-II study aimed to determine the maximum tolerated dose (MTD) of paclitaxel (Taxol), infused over 3 hours, when… 
1996
1996
Delivering emulsions of anthracycline drugs in Lipiodol, an iodinated poppy-seed oil, via the hepatic artery for the treatment of… 
1990
1990
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known…